AstraZeneca (Switzerland)

Recent papers from AstraZeneca (Switzerland)

1. Cardiopulmonary Event Prevalence Before First Recorded COPD Diagnosis: A Retrospective Cohort Study Using the Clinical Practice Research DatalinkInternational Journal of COPD · 2026
2. Baseline characteristics and antihypertensive patterns in Finnish patients with hypertension and kidney diseaseEuropean Heart Journal · 2026
3. Patient-Reported Disease Activity, Health-Related Quality of Life, and Coping in Systemic Lupus Erythematosus: A Cross-Sectional Online Survey in Switzerland (Lupus-IMPACT)Rheumatology and Therapy · 2026
4. Long-term cost-effectiveness of CKD screening in middle-aged adultsNephrology Dialysis Transplantation · 2026
5. Monoclonal Antibody Coformulations Reveal Three Interaction Patterns Governing StabilityMolecular Pharmaceutics · 2026
6. Epidemiology of Uncontrolled and Treatment‑Resistant Hypertension: A Registry‑Based Observational StudyBlood Pressure · 2026
7. Protocol for the Therapy Personalisation Using Multiomic Analyses in Inflammatory Bowel Disease (THAMES‐IBD) StudyJCC Plus · 2026
8. The Future of all‐Comers Trials in the Era of Precision OncologyClinical Pharmacology & Therapeutics · 2026
9. Patient and caregiver burden after hospitalization with severe viral lower respiratory tract disease: results from a real-world survey in Europe, the US and JapanCurrent Medical Research and Opinion · 2026
10. Regulatory T cell heterogeneity: who they are, where they come from, and where they goFrontiers in Immunology · 2026
11. Higher Pediatric Influenza Vaccination Coverage in Pooled Northern Hemisphere Countries with Public Access to Live Attenuated Influenza Vaccine: Implications for Immunization PolicyInfectious Diseases and Therapy · 2026
12. Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH studyClinical Cancer Research · 2026
13. Characteristics, treatment patterns, and outcomes of patients with transthyretin amyloidosis: a large-scale, observational, retrospective study in China (OverTTuRe China)Orphanet Journal of Rare Diseases · 2026
14. Estimating cumulative incidence from partially missing time series of respiratory viral infectionsPLoS ONE · 2026
15. Antihypertensive Medication Patterns in Patients with Hypertension that is Harder to Control: Insights from the EnligHTN StudyAdvances in Therapy · 2026
16. Autologous Glypican-3–Targeted, Armored CAR T Cells in Patients with Advanced Solid Tumors: A Phase 1 Dose-Escalation Study of TAK-102Cancer Immunology Research · 2026
17. Tozorakimab to Prevent COPD ExacerbationsNew England Journal of Medicine · 2026
18. Safety, Pharmacokinetics, and Predicted Neutralizing Activity of the SARS-CoV-2 Monoclonal Antibody Sipavibart: Results from Little DIPPER and the SUPERNOVA SubstudyInfectious Diseases and Therapy · 2026
19. Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United KingdomFrontiers in Cardiovascular Medicine · 2026
20. Burden and Risk Factors for Staphylococcus aureus-Related Sepsis among US Dialysis Patients: A Retrospective Claims-Based Cohort Study.2026